Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW0202 / UNK||- / IM|
Administered by: Private Purchased by: ??
Symptoms: Abdominal pain upper, C-reactive protein increased, Chest pain, Chest X-ray normal, Culture urine, Echocardiogram normal, Electrocardiogram ST segment elevation, Full blood count, Myocarditis, Urine analysis, Vaccination complication, Lipase, Ultrasound abdomen normal, Troponin increased, Metabolic function test
Life Threatening? Yes
Birth Defect? No
Permanent Disability? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 2
Write-up: Patient presented to the ED with 10/10 chest pain. Two days prior, he''d gotten his second COVID-19 pfizer vaccine. He denied any fever, congestion, cough, vomiting, diarrhea, or other signs of infection recently; no sick contacts. On arrival to the ED, he had normal vital signs, but physical exam was notable for sternal/epigastric pain. Laboratory evaluation, including CBC, CMP, CRP, urinalysis, urine culture, high sensitivity troponins, and lipase were obtained and notable for HS troponin of 303 pg/mL with a 2 hour repeat of 291 pg/mL. CRP was 3.5 mg/dL. His EKG had diffuse ST elevations. CXR was obtained with no evidence of cardiac border or consolidation. RUQ ultrasound showed no evidence of cholecystitis or other abnormality. Patient was admitted for presumed COVID-19 vaccine-induced myopericarditis. Echocardiogram showed normal biventricular function and no pericardial infusion. He was treated with IV toradol, with resolution of chest pain. HS troponins reached the 400s, with downtrend to the 300s prior to discharge. He was discharged on PO ibuprofen with follow-up cardiac MRI and labs.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166